Your browser doesn't support javascript.
loading
Point-of-care testing preferences 2020-2022: Trends over the years.
Howard-Wilson, Sakeina; Wang, Ziyue; Orwig, Taylor; Dunlap, Denise; Hafer, Nathaniel; Buchholz, Bryan; Sutaria, Shiv; McManus, David D; Lilly, Craig M.
Affiliation
  • Howard-Wilson S; Department of Medicine, UMass Chan Medical School, Worcester, Massachusetts.
  • Wang Z; Department of Medicine, UMass Chan Medical School, Worcester, Massachusetts.
  • Orwig T; Department of Medicine, UMass Chan Medical School, Worcester, Massachusetts.
  • Dunlap D; Manning School of Business, UMass Lowell, Lowell, Massachusetts.
  • Hafer N; UMass Center for Clinical and Translational Science, UMass Chan Medical School, Worcester, Massachusetts.
  • Buchholz B; Program in Molecular Medicine, UMass Chan Medical School, Worcester, Massachusetts.
  • Sutaria S; Department of Biomedical Engineering, UMass Lowell, Lowell, Massachusetts.
  • McManus DD; Department of Medicine, UMass Chan Medical School, Worcester, Massachusetts.
  • Lilly CM; Department of Medicine, UMass Chan Medical School, Worcester, Massachusetts.
Cardiovasc Digit Health J ; 5(3): 149-155, 2024 Jun.
Article in En | MEDLINE | ID: mdl-38989040
ABSTRACT

Background:

The use of point-of-care (POC) tests prior to the COVID-19 pandemic was relatively infrequent outside of the health care context. Little is known about how public opinions regarding POC tests have changed during the pandemic.

Methods:

We redeployed a validated survey to uncompensated volunteers to assess preferences for point-of-care testing (POCT) benefits and concerns between June and September 2022. We received a total of 292 completed surveys. Linear regression analysis was used to compare differences in survey average response scores (ARSs) from 2020 to 2022.

Results:

Respondent ARSs indicated agreement for all 16 POCT benefits in 2022. Of 14 POCT concerns, there were only 2 statements that respondents agreed with most frequently, which were that "Insurance might not cover the costs of the POC test" (ARS 0.9, ± 1.0) and "POC tests might not provide a definitive result" (ARS 0.1, ± 1.0). Additionally, when comparing survey responses from 2020 to 2022, we observed 8 significant trends for POCT harms and benefits.

Conclusion:

The public's opinion on POC tests has become more favorable over time. However, concerns regarding the affordability and reliability of POCT results persist. We suggest that stakeholders address these concerns by developing accurate POC tests that continue to improve care and facilitate access to health care for all.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cardiovasc Digit Health J Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cardiovasc Digit Health J Year: 2024 Document type: Article